Faculty Opinions recommendation of Efficacy of 8 weeks of sofosbuvir, velpatasvir, and voxilaprevir in patients with chronic HCV infection: 2 phase 3 randomized trials.

2019 ◽  
Author(s):  
George Cholankeril
Keyword(s):  
Randomized Trials ◽  
Hcv Infection ◽  
Phase 3 ◽  
Chronic Hcv Infection ◽  
Chronic Hcv

scholarly journals Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials

2017 ◽  
Vol 153 (1) ◽  
pp. 113-122 ◽  
Author(s):  
Ira M. Jacobson ◽  
Eric Lawitz ◽  
Edward J. Gane ◽  
Bernard E. Willems ◽  
Peter J. Ruane ◽  
...  
Keyword(s):  
Randomized Trials ◽  
Hcv Infection ◽  
Phase 3 ◽  
Chronic Hcv Infection ◽  
Chronic Hcv

Treatment of acute hepatitis C infection with interferon-alfa 2b monotherapy prevents development of chronic HCV infection

2001 ◽  
Vol 120 (5) ◽  
pp. A567-A567 ◽  
Author(s):  
E JAECKEL ◽  
M CORNBERG ◽  
T SANTANTONIO ◽  
J MAYER ◽  
H WEDEMEYER ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Acute Hepatitis ◽  
Interferon Alfa ◽  
Hcv Infection ◽  
Acute Hepatitis C ◽  
Hepatitis C Infection ◽  
Chronic Hcv Infection ◽  
Chronic Hcv

CD154 expression reveals the presence of dysfunctional virus-specific CD4+ T cells during chronic HCV infection

2008 ◽  
Vol 46 (01) ◽  
Author(s):  
N Semmo ◽  
M Müller ◽  
C Neumann-Haefelin ◽  
HC Spangenberg ◽  
HE Blum ◽  
...  
Keyword(s):  
T Cells ◽  
Cd4 T Cells ◽  
Hcv Infection ◽  
Chronic Hcv Infection ◽  
Chronic Hcv
Sign in / Sign up

Export Citation Format

Share Document